A cryptocurrency called Injective's price went up more than 5% in one day and 13% in a week. This means people are willing to pay more money for it now than before. The coin has been valued as high as $45 in the past, but right now it is at a lower price. The picture below shows how much the price of Injective changed over one day and one week compared to before. Read from source...

1. The title is misleading and does not reflect the actual content of the article. It implies that there was a sudden and significant increase in Injective's price within 24 hours, when in fact it was only 5.85%. This could be seen as an attempt to manipulate readers into clicking on the article with false expectations of a major event.

2. The article uses outdated data for Injective's all-time high, which is $45.01 according to CoinMarketCap. It also does not provide any context or explanation for why this is relevant or important for the current price performance. This could be seen as a lack of research and professionalism on the part of the author(s).

3. The article compares Injective's price movement and volatility over the past 24 hours to its price movement over the past week, without providing any comparison to other cryptocurrencies or the broader market. This could be seen as a lack of understanding of how crypto markets work and what factors influence prices. It also makes it difficult for readers to assess whether Injective's performance is exceptional or average in the context of the crypto space.

4. The article uses Bollinger Bands to measure volatility, but does not explain what they are or how they are calculated. This could be seen as a lack of clarity and education on the part of the author(s). It also makes it difficult for readers who are not familiar with technical analysis to understand and interpret the chart.

5. The article does not provide any analysis or commentary on why Injective's price has increased over the past week, what factors might be driving its performance, or whether there are any potential risks or challenges ahead. This could be seen as a lack of insight and value-added for readers who are interested in learning more about Injective and its prospects. It also makes it difficult for readers to make informed decisions based on the information provided in the article.